Multiparametric MRI In Characterization of Prostate Lesions Using PI-RADS Scoring System
IOSR Journal of Dental and Medical Sciences · 2026-01 · 25 (1) · 82-86
DOI: 10.9790/0853-2501028286 ↗Kurz gefasst
Fachartikel in der Zeitschrift IOSR Journal of Dental and Medical Sciences, 2026-01. Verfasst von Dr Itisha Agrawal und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Prostate cancer is one of the most common malignancies in men, and accurate detection of clinically significant lesions is crucial for optimal management. Multiparametric magnetic resonance imaging (mpMRI) with PI-RADS scoring has emerged as a non-invasive tool for lesion characterisation and risk stratification.
Objective
To evaluate the role of mpMRI in the characterisation of prostate lesions using the PI-RADS scoring system and to assess its diagnostic performance against histopathology. Materials and Methods: This prospective observational study included 80 male patients with clinical or biochemical suspicion of prostate lesions, conducted at RKDF Medical College Hospital & Research Centre over one year (January–December 2025). All patients underwent mpMRI, including T2-weighted imaging, diffusion-weighted imaging (DWI), and dynamic contrast-enhanced imaging (DCE). Lesions were scored according to PI-RADS v2.1, and all patients underwent prostate biopsy, which served as the reference standard. Diagnostic performance of mpMRI was evaluated in terms of sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy.
Results
The mean age of patients was 65.2 ± 7.8 years, and the mean PSA level was 18.5 ± 9.6 ng/mL. PIRADS distribution was: 1 (6.3%), 2 (12.5%), 3 (22.5%), 4 (37.5%), and 5 (21.2%). Clinically significant cancer was diagnosed in 55 patients (68.8%). mpMRI using PI-RADS ≥3 as positive demonstrated sensitivity 96.4%, specificity 71.0%, PPV 84.0%, NPV 92.0%, and overall accuracy 85.0%. Most significant lesions were located in the peripheral zone (72%).
Conclusion
Multiparametric MRI with PI-RADS scoring is a highly sensitive and reliable tool for the characterisation of prostate lesions. High PI-RADS scores (4–5) strongly correlate with clinically significant cancer, while low scores (1–2) are largely benign. mpMRI can guide targeted biopsy, improve detection, and reduce unnecessary procedures, supporting its integration into routine prostate cancer assessment
Zitieren
APA
Agrawal, D. I., Rao, D. F. R., & Raikwar, D. S. (2026). Multiparametric MRI In Characterization of Prostate Lesions Using PI-RADS Scoring System. IOSR Journal of Dental and Medical Sciences, 25(1), 82-86. https://doi.org/10.9790/0853-2501028286
Vancouver
Agrawal DI, Rao DFR, Raikwar DS. Multiparametric MRI In Characterization of Prostate Lesions Using PI-RADS Scoring System. IOSR Journal of Dental and Medical Sciences. 2026;25(1):82-86. doi:10.9790/0853-2501028286
BibTeX
@article{Agrawal2026,
author = {Agrawal, Dr Itisha and Rao, Dr Farha Rehman and Raikwar, Dr Santosh},
title = {Multiparametric MRI In Characterization of Prostate Lesions Using PI-RADS Scoring System},
journal = {IOSR Journal of Dental and Medical Sciences},
year = {2026},
volume = {25},
number = {1},
pages = {82--86},
doi = {10.9790/0853-2501028286}
}
EUVIMED